Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

JOURNAL OF INVASIVE CARDIOLOGY, a reputable publication by H M P COMMUNICATIONS, is dedicated to advancing the field of cardiology and cardiovascular medicine through rigorous research and scholarly discussion. With an ISSN of 1042-3931 and an E-ISSN of 1557-2501, this journal serves as a crucial resource for healthcare professionals, researchers, and students who seek to stay informed about the latest findings and innovations in invasive cardiology. Having achieved a 2023 Scopus rank of #185 out of 636 in General Medicine, placing it in the 70th percentile, the journal is recognized for its significant contributions to medical science, evidenced by its Q2 ranking in Radiology, Nuclear Medicine and Imaging, and Q3 status in both Cardiology and Cardiovascular Medicine. The journal has been in circulation since 1990 and continues to foster a platform for critical research in the United States, ensuring accessibility to vital information necessary for enhancing patient care and clinical practices within the domain of invasive procedures.

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

Kardiologia Polska, the esteemed journal of the Polish Cardiac Society, has established itself as a vital resource in the field of cardiology and cardiovascular medicine since its inception in 1954. With an ISSN of 0022-9032 and an E-ISSN of 1897-4279, this journal serves as a platform for groundbreaking research and scholarly articles that contribute to the advancement of heart health. Although currently not an open access journal, it remains an essential reference for practitioners and researchers seeking to stay abreast of the latest developments in cardiovascular science. The journal reflects its scholarly depth through a Category Quartile of Q3 and a commendable Scopus ranking at the 48th percentile in its field. Published primarily in Poland, it caters to a global audience eager to explore comprehensive studies spanning clinical cardiology, innovative therapeutic approaches, and emerging cardiovascular trends. Join a thriving academic community by engaging with the invaluable insights and research contributions found within the pages of Kardiologia Polska.

Circulation-Cardiovascular Imaging is a prestigious journal published by LIPPINCOTT WILLIAMS & WILKINS, dedicated to advancing the field of cardiovascular imaging through high-quality research and review articles. With an impact factor placing it in the Q1 category across key areas including Cardiology and Cardiovascular Medicine, Medicine (miscellaneous), and Radiology, Nuclear Medicine and Imaging, this journal fosters scholarly communication among leading experts and emerging researchers. Established in 2008, it has rapidly become an essential resource for academics and professionals, given its commitment to disseminating groundbreaking findings and methodologies that influence clinical practices and patient outcomes. Circulation-Cardiovascular Imaging is designed to engage a wide audience, from seasoned practitioners to students keen on exploring the nexus of cardiology and innovative imaging techniques. Its significant visibility in the medical literature underscores its role as a cornerstone in the evolution of cardiovascular diagnostics and patient care.

Canadian Journal of Cardiology (ISSN: 0828-282X, E-ISSN: 1916-7075), published by Elsevier Science Inc, serves as a vital platform for disseminating high-quality research in the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1985, this journal has established itself as a leader in the field, currently holding a prestigious Q1 ranking in Cardiology, indicating its significant impact and contribution to medical science. With a Scopus rank of #50 out of 387 in its category and placing in the 87th percentile, the journal showcases rigorous peer-reviewed articles that advance knowledge and practice in cardiology. Although the journal is not open access, it provides valuable insights and research findings that cater to clinicians, researchers, and students who are committed to improving cardiovascular health. As we approach the convergence of years to 2024, the Canadian Journal of Cardiology continues to strive for excellence, facilitating a discourse vital for both academic and clinical advancements in cardiology.

The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.

Cardiovascular Intervention and Therapeutics, published by SPRINGER JAPAN KK, stands as a prominent journal within the fields of cardiology and cardiovascular medicine, reflecting its commitment to disseminating groundbreaking research and clinical advances. With an impressive Q2 ranking in Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous), and a Q1 ranking in Radiology, Nuclear Medicine and Imaging, this journal employs rigorous peer-review processes to ensure the quality and relevance of its content. Catering to a diverse audience of researchers, clinicians, and students, the journal aims to foster innovation and enhance understanding through the publication of original research, reviews, and clinical studies focused on cardiovascular interventions and therapies. Spanning over a decade of evolution from 2010 to 2024, Cardiovascular Intervention and Therapeutics continues to be a vital resource for advancing knowledge and practice in the cardiovascular field. Explore the latest advancements and insights that this esteemed journal has to offer, and contribute to the ongoing dialogue that shapes modern cardiovascular medicine.

CORONARY ARTERY DISEASE, published by Lippincott Williams & Wilkins, stands as a vital contributor to the field of cardiology and cardiovascular medicine. Established in 1990, this esteemed journal presents cutting-edge research and insights from internationally recognized experts, facilitating the advancement of knowledge on coronary artery diseases. With its current impact factor placing it in the Q3 category for both Cardiology and Cardiovascular Medicine as well as miscellaneous Medicine, this journal is a valuable resource for researchers, healthcare professionals, and students alike, eager to stay abreast of developments in this critical area of health. Although it does not offer open access, articles published within its pages continue to influence clinical practice and healthcare strategies significantly. Situated at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103, the journal engages a global audience, maintaining a commitment to showcasing innovative research until at least 2024. Engage with CORONARY ARTERY DISEASE to enhance your understanding and foster progress in cardiovascular health.

Journal of Cardiovascular and Thoracic Research is a premier open access journal published by Tabriz University of Medical Sciences & Health Services, focusing on the dynamic fields of cardiology and cardiovascular medicine. With an ISSN of 2008-5117 and E-ISSN 2008-6830, the journal provides a platform for innovative research and advances in cardiovascular and thoracic health, catering to a global audience of researchers, healthcare professionals, and students. Since its inception as an open access publication in 2010, the journal has established itself within the academic community, evidenced by its inclusion in Scopus and its category quartile ranking (Q3) in 2023. Located in Tabriz, Iran, the journal aims to disseminate high-quality studies that contribute to the understanding and treatment of cardiovascular diseases, thus enabling advancements in this critical field of medicine. With a Scopus rank of 248 out of 387 in the category of Cardiology and Cardiovascular Medicine, the Journal of Cardiovascular and Thoracic Research is dedicated to fostering collaboration and dialogue among researchers and practitioners, promoting a deeper understanding of cardiovascular and thoracic health.